Scholarlink

Background <p>Artificial Intelligence (AI) is increasingly proposed to enhance population-based cancer screening. While several applications are under evaluation, there is limited evidence on professional and organisational perspectives regarding their value, risks, and implementation challenges.</p> Methods <p>We conducted a web-based survey targeting coordinators and reference professionals of Italian cancer screening programmes. The survey comprised 39 questions and explored prior experience with AI, perceived benefits and risks, organisational and legal barriers, and willingness to invest in AI applications. Recruitment combined a cascade procedure through regional and sub-regional coordinators with distribution via the mailing list of the Federation of Oncology Screening Associations (FASO). Descriptive analyses summarised responses, while multiple linear regression assessed determinants of willingness to invest in AI applications.</p> Results <p>A total of 305 professionals responded, representing all but one Italian region. About one-third reported AI experience, most frequently in colorectal polyp detection and breast imaging support. Overall, 74.8% expressed a strong interest in adopting AI applications, particularly for risk prediction and diagnostic support. The most valued benefits were improved diagnostic accuracy, workflow optimisation, and shorter reporting times. Concerns focused on legal liability (72.8%), lack of transparency and algorithmic bias (67.2%), and professional de-skilling (46.2%). Organisational barriers included inadequate IT infrastructure (77.0%), absence of guidelines (75.7%), and limited financial resources (77.4%). Regression confirmed that higher perceived benefits were positively associated with willingness to invest in AI applications, whereas risks were negatively associated.</p> Conclusions <p> Italian screening professionals generally support the adoption of AI but emphasise the need for robust evidence, clear regulatory frameworks, and sustained investment in digital infrastructure to ensure its safe and effective implementation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Artificial intelligence in population-based cancer screening: evidence from a national survey of Italian professionals

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月26日

查看全文
  • Giovanni Fattore,
  • Mattia Benato Cortecci,
  • Renato Fasoli,
  • Tiziano Maggino,
  • Paola Mantellini,
  • Silvia Deandrea

摘要

Background

Artificial Intelligence (AI) is increasingly proposed to enhance population-based cancer screening. While several applications are under evaluation, there is limited evidence on professional and organisational perspectives regarding their value, risks, and implementation challenges.

Methods

We conducted a web-based survey targeting coordinators and reference professionals of Italian cancer screening programmes. The survey comprised 39 questions and explored prior experience with AI, perceived benefits and risks, organisational and legal barriers, and willingness to invest in AI applications. Recruitment combined a cascade procedure through regional and sub-regional coordinators with distribution via the mailing list of the Federation of Oncology Screening Associations (FASO). Descriptive analyses summarised responses, while multiple linear regression assessed determinants of willingness to invest in AI applications.

Results

A total of 305 professionals responded, representing all but one Italian region. About one-third reported AI experience, most frequently in colorectal polyp detection and breast imaging support. Overall, 74.8% expressed a strong interest in adopting AI applications, particularly for risk prediction and diagnostic support. The most valued benefits were improved diagnostic accuracy, workflow optimisation, and shorter reporting times. Concerns focused on legal liability (72.8%), lack of transparency and algorithmic bias (67.2%), and professional de-skilling (46.2%). Organisational barriers included inadequate IT infrastructure (77.0%), absence of guidelines (75.7%), and limited financial resources (77.4%). Regression confirmed that higher perceived benefits were positively associated with willingness to invest in AI applications, whereas risks were negatively associated.

Conclusions

Italian screening professionals generally support the adoption of AI but emphasise the need for robust evidence, clear regulatory frameworks, and sustained investment in digital infrastructure to ensure its safe and effective implementation.